The 14th National Clinical Conference
on Cannabis Therapeutics
May 20-22, 2021
Attendees who complete this educational activity can earn 15.5 AMA PRA Category 1 Credit(s) ™ or 15.5 CPE Contact Hours. All other participants should receive a certificate of completion.
The 14th National Clinical Conference on
Cannabis Therapeutics: State of the Science
May 20-22, 2021.
The expansion of legal access to medical cannabis requires health care professionals to have up to date, reliable, and scientifically supported education and training.
Patients Out of Time is pleased to present The Fourteenth National Clinical Conference on Cannabis Therapeutics in a virtual, online format from Thursday May 20th through Saturday, May 22. The theme of the conference is “The State of the Science”, and our goal is to provide attendees with a clear overview of the current status of the known and unknown factors associated with the therapeutic use of cannabis. This virtual conference is designed for healthcare professionals as well as the general public and will be held online. The conference will be hosted by Mary Lynn Mathre RN, MSN, President of Patients Out of Time, with a special welcome from Dr. Mikhail Kogan of the George Washington University, Center for Integrative Medicine, co-sponsor of this event.
Thursday, May 20, 2021
11:00 – 11:30am Welcome and Overview – M. L. Mathre, RN, MSN & Mikhail Kogan, MD
11:30 – 1:10 pm State of Cannabis Laws and Regulations - The Invisible Patient
11:30 – 11:55 am The Broad Scope of Patient Needs - Jon Gettman, PhD
11:55 – 12:20 pm Minorities and Veterans – Brandon Wyatt, Esq
12:20 – 12:45 pm Reclassification of Cannabis in the Single Convention Drug Control Treaty Pursuant to Critical Review Process of World Health Organization’s Expert Committee on Drug Dependence: Implications for Policy, Patient Access, and the Cannabis Industry Inside the US - Michael Krawitz
12:45 – 1:10 pm Live Q & A with faculty
1:10 – 1:15 Break
1:15 – 2:50 State of Cannabis Research – Catch 22
1:15 – 1:33 pm Early Attempts at Cannabis Research – Melanie Dreher, PhD, RN
1:33 – 1:51 pm Is the End of the University of Mississippi’s Monopoly in Sight? – Sue Sisley, MD with Shane Pennington and Matt Zorn
1:52 – 2:10 pm Four Years after the 2017 NASEM report on The Health Effects of Cannabis and Cannabinoids: What We’ve Learned and Where We’re Headed – Ziva Cooper, PhD
2:11 – 2:29 pm Research Interests of the National Center for Complimentary and Integrative Health – David Shurtleff, PhD
2:30– 2:50 pm Live Q & A with faculty
2:50 – 3:00 pm Break
3:00 – 4:30 pm State of Cannabis Education – Who is Teaching Who?
3:00 – 3:15 pm Nursing survey - Yolanda Nitti, RN, PhD
3:15 – 3:30 pm MD University Cannabis program - Leah Sera, PharmD
3:30 – 4:00 pm Core Steps Toward Developing Competencies for Medical Cannabis Education in Medical Schools - Mikhail Kogan, MD, Yuval (Tuby) Zolotov, PhD, Leslie Mendoza Temple, MD, Abraham Benavides, MD
4:00 – 4:30 pm Q & A with faculty
Friday, May 21, 202
11:00 – 5:00 pm State of the Science - What We Do Know About the ECS and Cannabis
11:00 – 11:45am Overview: What We do Know About the ECS and Cannabis - Greg Gerdeman, PhD
11:45 – 12:30 pm Matters of MIND: Examining the Impact of Medical Cannabis – Staci Gruber, PhD
12:30 – 12:40 pm Break
12:40 - 1:20 pm Cannabis as an Orchestra of Components for a Multitude of Conditions - David (Dedi) Meiri, PhD
1:20 – 2:00 pm Mechanism of Action of CBD & Other Cannabinoids – Bonni Goldstein, MD
2:00 – 2:40 pm State of Product Safety – Jahan Marcu, PhD
2:40 – 2:55 pm Break
2:55 – 3:40 pm The Endocannabinoid System, Cannabis, and the Microbiome – Ethan Russo, MD
3:40 – 4:20 pm Medicinal Plants: Missing Insights on Pharmacology - Kevin Spelman, PhD
4:20 – 5:00 pm Q & A – State of the Science Faculty
Saturday, May 22, 202
11:00 – 5:00pm State of Clinical Practice – Science Takes Hold
11:00 – 11:10 am Welcome and Announcements
11:10– 11:50 pm Challenges, Successes and New Challenges - Dustin Sulak, DO
11:50 – 12:05 pm Cannabis Preferences by a Cohort of Veterans in Hawaii - Me Fuimanono-Poe, FNP-BC
12:05 – 12:25 pm 2019 Veterans Health and Medical Cannabis Study – Marion McNabb, PhD
12:25 – 12:35 pm Break
12:35 – 1:15 pm Cannabis and Women’s Health Conditions – Genester Wilson-King, MD
1:15 – 1:45 pm Pediatric Case Presentations – Rylie Maedler and Coltyn Turner (Crohn’s disease)
1:45 -2:15 pm What About the Children? – Patricia Frye, MD
2:15 – 2:45 pm Cannabis Therapeutics for the Geriatric Population - Mikhail Kogan, MD
2:45 – 2:50 pm Break
2:50 – 3:20 pm COVID-19 and Medical Cannabis Patients and Consumer Study – Marion McNabb, DrPH, MPH
3:20 – 4:10 pm CBD for the Treatment of Diabetic Neuropathic Pain – Deb Kimless, MD
4:10 – 5:00 pm Live Q & A – State of Clinical Practice faculty
For 25 years, Patients Out of Time’s accredited clinical conference series has been internationally regarded for providing the best in science based education for medical professionals, caregivers, patients and the public on the subject of cannabis therapeutics, establishing the organization as an authoritative leader in this field.
Join Patients Out of Time for this 3 day event. On Thursday, May 20th, examine contemporary laws and regulations, research opportunities, and education related to the therapeutic use of cannabis. Friday, May 21st will feature leading scientists and researchers presenting recent up to date evidence-based science as it is linked to the endocannabinoid system and cannabis therapeutics. And on Saturday, May 22nd, the conference concludes with a line-up of cannabis clinicians, patients, and researchers who will share how cannabis is integrated into healthcare for various populations based on scientific evidence. Registrants will be able to access all of the conference programming through the end of May.
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education..
Click here for Full Faculty List
Ethan Russo, MD
Greg Gerdeman, PhD
Staci Gruber, PhD
Bonni Goldstein, MD
Genester Wilson-King, MD
Deb Kimless, MD
Patricia Frye, MD
Marion McNabb, DrPH, MPH
Sue Sisley, MD
Kevin Spelman, PhD
Ziva Cooper, PhD
Misha Kogan, MD
Dustin Sulak, MD
Mary Lynn Mathre, RN, MSN
David (Dedi) Meiri, PhD
Jahan Marcu, PhD, PA
Jon Gettman, PhD
Melanie Dreher, RN, PhD
Leigh Frame, PhD, MHS
Me Fuimaono- Poe, FNP-BC
David Shurtleff, PhD
Michael Krawitz, Esq.
Rylie Maedler (Patient)
Coltyn Turner (Patient)
Featured Faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationDr. Staci Gruber Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of...
Featured Faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationMarion McNabb, DrPH, MPH Marion McNabb, DrPH, MPH is the President of Cannabis Center of Excellence, INC a 501c3 nonprofit organization that conducts citizen-science focused...
Featured Faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationMary Lynn Mathre, RN, MSN, CARN Mary Lynn (ML) Mathre is the President and Co-founder of Patients Out of Time and Past President and Founding Member of the American Cannabis...
Featured Faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationDr. Dustin Sulak Dustin Sulak, D.O. is an osteopathic physician, licensed in Maine as a general practitioner. He is an expert in integrative medicine, the intelligent...
Featured Faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationBonni Goldstein, MD Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness and Education, a California-based medical practice devoted to educating patients...
Featured Faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationAbraham Benavides, MD R1 Resident Family Physician, Swedish Family Medicine – First Hill International Cannabis Consultant and Author Founder, Cannabis as Medicine Interest...
Featured Faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationEthan Russo, MD Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com Previously he was...
Featured Faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationDebra Kimless, M.D. Debra Kimless, M.D. graduated magna cum laude, Phi Beta Kappa from Muhlenberg College with a double major in Natural Sciences and Biology. She attended...
Featured faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationDr. Sera Dr. Sera is an Associate Professor in the Department of Pharmacy Practice and Science and Program Director for the Master of Science in Medical Cannabis Science and...
Featured faculty at the State of the Science Online conference, May 20 - May 22 | RegistrationDr. Jon Gettman Jon Gettman is an Associate Professor of Criminology and Criminal Justice at Shenandoah University. He is best known in the medical cannabis community for...
Exhibitor Showcase Signup
State of The Science, Exhibitor Showcase
TrulieveTrulieve is the first and leading medical cannabis company in the state of Florida, the third most populous state in the United States. Its vertically-integrated "seed-to-sale" operation has approximately 51% of the Florida market. Trulieve boasts over 550+...
UNDOO Who is UNDOO®? UNDOO, LLC was founded with the vision to improve patients and consumer’s lives as they navigate the ever-growing Cannabis industry. Our Company is dedicated to bringing revolutionary new products to the Cannabis space with the science to back...
Geocann, LLCGeocann is a global cannabis organization led by experienced leadership with scientific and technical expertise for pioneering new innovations in natural health products and solutions. Its focus is combining clinically-researched cannabinoids with...
Doctors for Cannabis RegulationDoctors for Cannabis Regulation serves as a global voice for physicians and other health professionals who support cannabis legalization and science-based regulation.facebooktwitterinstagramlinkedin#kindfinejewelry #420...
United Patients GroupSince 2011, United Patients Group (UPG) has been an unparalleled resource and trusted leader in Medical Cannabis for physicians, patients and organizations. UPG acts as a virtual hand for patients and their families, by helping them navigate...
Kind Fine Jewelry The mission of Kind Fine Jewelry is to elevate cannabis into the world of luxury jewelry. Kind Fine Jewelry pieces present a sophisticated expression of beauty, yet they are practical enough for everyday wear. The highest quality materials are hand...
HealerHealer’s mission is to empower people to live life to its fullest in great health. We achieve this through education, advocacy, and research. We offer unmatched expertise in the correct use of medical cannabis, and through the educational programs on this site,...
Dr. Bronner's ALL-ONEOur Cosmic Principles define our most important relationships, and guide us in everything we do, from soapmaking to peacemaking – All-One! Dr. Bronner's Magic Soaps is an American producer of organic soap and personal care products headquartered...
Society of Cannabis CliniciansOur mission is to provide continuing education for ourselves, our patients, and our colleagues about the medical use of cannabis and best practices in clinical care. The Society of Cannabis Clinicians is the first and oldest U.S. medical...
Online Exhibitor ShowcaseMarket Impact $750 ($2k Value) 1x Public Pass ($225) Dedicated Video Ad, Tier 1 ($650) Exhibitor Portal Ad Sq ($350) Registration Ad Sq ($350) Dedicated Post ($250) 4x Social Media ($200) Community Builder $350 ($900 Value) Exhibitor Portal...
Patients Out of Time has prepared this resolution to De-Schedule Cannabis with the goal of creating a large and ever growing coalition of organizations and individuals to demand the end of the cannabis prohibition. It has been 50 years since the passage of the Controlled Substances Act in which cannabis (marijuana) was placed in the forbidden category of Schedule I, despite several legal proceedings to remove it from the list of controlled substances and clear scientific evidence to support its safety and efficacy. While individual states have passed laws through voter initiatives or legislation to allow patient access to this plant, the overriding federal prohibition looms overhead and creates numerous roadblocks for patient access. We the people need to demand an end to the prohibition of this highly beneficial plant.
Shop through Amazon using the link below to support Patients Out of Time! Amazon donates to Patients Out of Time for every purchase you make.
Society of Cannabis Clinicians | American Cannabis Nurses Association | United Patients Group | Veterans for Medical Cannabis Access | American Academy of Cannabinoid Medicine | International Association of Cannabinoid Medicine | Students for Sensible Drug Policy | Athletes for Care | Veterans Cannabis Project
The conference was the very best example of good science and compassion for patients. Excellent organization!
Patients Out of Time works to re-institute cannabis as a legitimate medicine for use within the United States. Cannabis, under modern research protocols, has been found to be effective in reducing intraocular pressure in glaucoma, reducing nausea and vomiting associated with chemotherapy, stimulating the appetite for persons living with AIDS and suffering from wasting syndrome, controlling spasticity associated with spinal cord injury and multiple sclerosis, treating Dravet Syndrome, reducing the intensity of chronic pain, assisting with treatment for post-traumatic stress disorder, and controlling seizures associated with seizure disorders.